Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial
events) is highly consequential for patients with cancer and is associated with worsened …

Patients with cancer are at higher risk of developing venous thromboembolism (VTE)
compared with the general population. This elevated risk is due to several risk factors and …

Patients with cancer are characterized by a dysregulation of the hemostatic system and
systemic hypercoagulability. Different components of the hemostatic system are involved in …

Background: Cancer-associated venous thromboembolism (VTE) is a critical complication in
patients with cancer. However, the pathological findings of VTE are limited. Here, we …

Oxidative protein folding occurs in the endoplasmic reticulum (ER) to generate disulfide
bonds, and the by‐product is hydrogen peroxide (H2O2). However, the relationship between …

Patients with cancer have an increased risk of venous-and arterial thromboembolism
(VTE/ATE). Anti-cancer treatments including surgery, radiotherapy, and certain …

Objective: Pancreatic cancer activates coagulation and increases risk of venous
thromboembolism (VTE). We aimed at characterizing the association of hemostatic …

Cerebral cavernous malformation (CCM) is a neurovascular disease that results in various
neurological symptoms. Thrombi have been reported in surgically resected CCM patient …

Aside from their key protective roles in hemostasis and innate immunity, platelets are now
recognized as having multifaceted, adverse roles in the pathogenesis, progression and …

In patients with cirrhosis, particularly those with hepatocellular carcinoma (HCC),
hypercoagulability may be associated with purported increased risks of portal vein …